Nomura Securities on Emerson (EMR): Valuation Remains Attractive; Invensys Good Fit on Right Terms

June 21, 2012 9:55 AM EDT Send to a Friend
Nomura Securities maintains a 'Buy' on Emerson (NYSE: EMR) price target of $64.00.

Analyst, Shannon O'Callaghan, said, "The idea ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login